Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Cancer Letters
|
January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Scientific Reports
|
April 30, 2021
Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
Rachel Martini, Yalei Chen, Brittany D Jenkins, et al.
Cancer Research
|
February 1, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann, et al.
Archives of Pathology & Laboratory Medicine
|
January 20, 2024
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition
Yungtai Lo, Susan C Lester, Ian O Ellis, et al.
Nature Cell Biology
|
November 6, 2019
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
Gonçalo Rodrigues, Ayuko Hoshino, Candia M Kenific, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Cancer Letters
|
January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
Scientific Reports
|
April 30, 2021
Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
Rachel Martini, Yalei Chen, Brittany D Jenkins, et al.
Cancer Research
|
February 1, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann, et al.
Archives of Pathology & Laboratory Medicine
|
January 20, 2024
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition
Yungtai Lo, Susan C Lester, Ian O Ellis, et al.
Nature Cell Biology
|
November 6, 2019
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
Gonçalo Rodrigues, Ayuko Hoshino, Candia M Kenific, et al.
Page
of 7